But, we need to hear more as Pax alone beats the current standard of care by a notable margin so it will be interesting to unpack this and find out why they are not moving to stage 2 in this arm for GBM… still two other arms in this trial as well as all the other separate trials in stages 1 & 2.
I think it would be good for James to hit the interview button.
I’ve taken advantage of this over reaction to top up again.
KZA Price at posting:
27.0¢ Sentiment: Buy Disclosure: Held